Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Krishna Institute of Medical Sciences's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 0.13%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
NSE:KIMS's 3-Year ROIIC % is ranked worse than 55.48% of 620
companies
in the Healthcare Providers & Services industry
Industry Median: 3.37
vs NSE:KIMS: 0.13
Krishna Institute of Medical Sciences (NSE:KIMS) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Krishna Institute of Medical Sciences 3-Year ROIIC % Related Terms
Krishna Institute of Medical Sciences 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krishna Institute of Medical Sciences 3-Year ROIIC % Chart
NSE:KIMS vs HCA, THC, DVA: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Krishna Institute of Medical Sciences's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krishna Institute of Medical Sciences 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Krishna Institute of Medical Sciences's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Krishna Institute of Medical Sciences's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Krishna Institute of Medical Sciences (NSE:KIMS) has a 3-Year ROIIC % of 0.13 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Krishna Institute of Medical Sciences and its competitors. This is 98% below median its historical median of 5.86. Over the past decade, Krishna Institute of Medical Sciences' 3-Year ROIIC % has ranged from 0.13 to 37.46. According to the industry distribution chart, Krishna Institute of Medical Sciences ranks #344 out of 620 companies in the Healthcare Providers & Services industry, placing it in the top 55.5%.
Is Krishna Institute of Medical Sciences' 3-Year ROIIC % too high?
Krishna Institute of Medical Sciences' current 3-Year ROIIC % of 0.13 is 98% below median its 10-year median of 5.86. Over the past 10 years, this metric has ranged from a low of 0.13 to a high of 37.46. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.37. Krishna Institute of Medical Sciences' value of 0.13 is 96.1% below this industry median. Based on the distribution chart, Krishna Institute of Medical Sciences ranks #344 out of 620 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Krishna Institute of Medical Sciences has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Krishna Institute of Medical Sciences' 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Krishna Institute of Medical Sciences ranks #344 out of 620 companies for 3-Year ROIIC %. This places Krishna Institute of Medical Sciences in the lower half of its industry. The industry median 3-Year ROIIC % is 3.37. Krishna Institute of Medical Sciences' value of 0.13 is 96.1% below this benchmark. Historically, Krishna Institute of Medical Sciences' own 3-Year ROIIC % has ranged from 0.13 to 37.46 over the past decade. While the company's 10-year median is 5.86 vs. the industry median of 3.37, Krishna Institute of Medical Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.37, based on 620 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krishna Institute of Medical Sciences's current 3-Year ROIIC % of 0.13 is 96.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Krishna Institute of Medical Sciences and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krishna Institute of Medical Sciences's current 3-Year ROIIC % is 0.13, which is 98% below median its own 10-year median of 5.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krishna Institute of Medical Sciences stock overvalued right now?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences (NSE:KIMS) is currently considered Fairly Valued. The stock's GF Value™ is ₹795.63, compared to a current price of ₹798.00 — trading 0.3% above its estimated fair value. The current 3-Year ROIIC % is 0.13, which is 98% below median its 10-year median of 5.86 and 96.1% below the Healthcare Providers & Services industry median of 3.37. Krishna Institute of Medical Sciences' overall GF Score™ is 87/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Krishna Institute of Medical Sciences (NSE:KIMS), the current 3-Year ROIIC % is 0.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krishna Institute of Medical Sciences (NSE:KIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences stock appears to be overvalued.
The current stock price of ₹798.00 is trading 0.3% above its estimated GF Value™ of ₹795.63.
GuruFocus considers Krishna Institute of Medical Sciences to be Fairly Valued.
Key valuation signals for NSE:KIMS:
3-Year ROIIC %: 0.13 (98% below median its 10-year median of 5.86)
GF Value™: ₹795.63 vs. price of ₹798.00 (0.3% above fair value)
Industry Position: 96.1% below the Healthcare Providers & Services median (#344 of 620)
No single metric tells the full story. See the NSE:KIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krishna Institute of Medical Sciences Business Description
Krishna Institute of Medical Sciences Ltd is a healthcare group in Secunderabad and Telangana. It offers a comprehensive range of healthcare services, including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, mother and child care, and many more. The firm generates key revenue from Hospital services and Pharmacy.
87GF Score
Get the complete analysis for NSE:KIMS
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KIMS has been successfully added to your 
